Silver Nanoparticles Selectively Treat Neurofibromatosis Type 1-Associated Malignant Peripheral Nerve Sheath Tumors in a Neurofibromin-Dependent Manner.

Alewine, Garrett; Knight, Jerrica; Ghantae, Adithya; Mamrega, Christina; Attiah, Bashnona; Coover, Robert A; Fahrenholtz, Cale D

Alewine, Garrett; Knight, Jerrica; Ghantae, Adithya; Mamrega, Christina; Attiah, Bashnona; Coover, Robert A; Fahrenholtz, Cale D.

Afiliación

Alewine G; Department of Basic Pharmaceutical Sciences, Fred Wilson School of Pharmacy, High Point University, High Point, NC 27268, USA.
Knight J; Department of Basic Pharmaceutical Sciences, Fred Wilson School of Pharmacy, High Point University, High Point, NC 27268, USA.
Ghantae A; Department of Basic Pharmaceutical Sciences, Fred Wilson School of Pharmacy, High Point University, High Point, NC 27268, USA.
Mamrega C; Department of Basic Pharmaceutical Sciences, Fred Wilson School of Pharmacy, High Point University, High Point, NC 27268, USA.
Attiah B; Department of Basic Pharmaceutical Sciences, Fred Wilson School of Pharmacy, High Point University, High Point, NC 27268, USA.
Coover RA; Department of Basic Pharmaceutical Sciences, Fred Wilson School of Pharmacy, High Point University, High Point, NC 27268, USA.
Fahrenholtz CD; Department of Basic Pharmaceutical Sciences, Fred Wilson School of Pharmacy, High Point University, High Point, NC 27268, USA.

J Pers Med ; 12(7)2022 Jun 30.

Article en En | MEDLINE | ID: mdl-35887576

Palabras clave

malignant peripheral nerve sheath tumors; nanomedicine; neurofibromatosis type 1; oncology; silver nanoparticles

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: J Pers Med Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google